Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 35 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
341 20.5 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Stanford University School of Medicine United States 11/2008
Treatment Details: Patients: This phase 2 study involved 45 patients with metastatic colorectal cancer. The median age was 57, ranging from 29 to 79 years of age. These patients had not received any previou
 
342 20.5 months Newly diagnosed GBM 4 Chemotherapy
Radiation
Duke University Medical Center United States 8/2009
Treatment Details: Patients: This study involved 85 newly diagnosed patients with glioblastoma multiforme. Forty-nine of the patients had a median age of 54, ranging from 24 to 76 years. The other thirty-six
 
343 20.5 months Metastatic melanoma 4 Biologic therapy
Chemotherapy
Fondazione IRCCS Istituto Nazionale dei Tumori Italy 12/2010
Treatment Details: Patients: This study involved 20 previously untreated metastatic melanoma patients with a median age of 54 years (range of 22-75). Sixty (60) percent of the patients were male. Treatmen
 
344 20.5 months Metastatic colorectal adenocarcinoma 5 Chemotherapy
David Geffen School of Medicine at University of California, Los Angeles United States 5/2011
Treatment Details: Patients: This phase 3 study involved metastatic colorectal adenocarcinoma patients who were divided into two separate treatment groups. Group A consisted of 585 patients with an average a
 
345 20.5 months Metastatic colorectal cancer 3 Chemotherapy
Christie Hospital United Kingdom 5/2011
Treatment Details: Patients: This phase II study involved 45 patients with previously untreated metastatic colorectal cancer. The median patient age was 58 and 62% were male. Treatment: Patients were tre
 
346 20.4 months Metastatic breast cancer 4 Chemotherapy
University General Hospital of Heraklion Greece 9/2011
Treatment Details: Patients: This phase III study involved women with metastatic breast cancer who had previously received chemotherapy. These patients were divided into two separate treatment groups. Group
 
347 20.4 months Metastatic colorectal cancer 4 Chemotherapy
Oslo University Hospital Norway 5/2012
Treatment Details: Patients: This study involved previously untreated metastatic colorectal cancer patients who were divided into separate treatment groups. Group A consisted of 185 patients with a median a
 
348 20.4 months Advanced colorectal cancer 4 Chemotherapy
Institut Bergonié, Regional Cancer Center France 12/2007
Treatment Details: Patients: This phase II study involved 80 patients with advanced colorectal cancer. They ranged in age from 41 to76 years old. There were about twice as many men in this study as there we
 
349 20.3 months ALK-positive lung cancer 5 Biologic therapy
Massachusetts General Hospital United States 6/2013
Treatment Details: Patients: This phase 3 study involved ALK-positive lung cancer patients who had received prior platinum-based chemotherapy. Patients were divided into two separate treatment groups. Group
 
350 20.2 months advanced breast cancer 3 Hormone
Mayo Clinic and Mayo Foundation United States 3/2006
Treatment Details: Patients: This phase II study involved 77 patients (median age 68) with advanced breast cancer who experienced disease progression after treatment with a third generation aromatase inhibito
 
Page 35 of 187  | Previous Page  | Next Page